Index of reports
> Cases with Fatigue (140)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 140 Next >>
Possible Xeloda side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 101.7 kg (223.7 pounds)
Reactions: Death, Fatigue, Vomiting
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Xeloda
Administration route: Oral
Indication: Bile Duct Cancer
Start date: 2012-02-06
Other drugs received by patient: Prochlorperazine; Prochlorperazine
Possible Xeloda side effects in 62 year old female
Reported by a physician from United States on 2012-08-27
Patient: 62 year old female
Reactions: Mucosal Inflammation, Fatigue, Diarrhoea, Mental Status Changes, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Indication: Colorectal Cancer Metastatic
Avastin
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in 69 year old female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: 69 year old female
Reactions: Phlebitis, Breast Cancer, Fatigue, Diarrhoea, Decreased Appetite, Disease Progression
Drug(s) suspected as cause:
Xeloda
Indication: Product Used FOR Unknown Indication
Tykerb
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Xeloda side effects in 50 year old female
Reported by a physician from Canada on 2012-08-24
Patient: 50 year old female
Reactions: Breast Cancer, Skin Exfoliation, DRY Skin, Paraesthesia, Fatigue, Neoplasm Malignant, Ocular Hyperaemia, Eye Swelling, Lacrimation Increased, Metastases To Central Nervous System
Drug(s) suspected as cause:
Xeloda
Indication: Product Used FOR Unknown Indication
Tykerb
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Xeloda side effects in 53 year old male
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient: 53 year old male
Reactions: Confusional State, Agitation, Dysphagia, Pain, Anaemia, Failure To Thrive, Hypokalaemia, Death, Fatigue, Fluid Intake Reduced, Asthenia, Decreased Appetite, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Nexavar
Dosage: 400 mg am, 200 mg pm x 21days
Indication: Colorectal Cancer Metastatic
Start date: 2012-06-22
End date: 2012-08-07
Xeloda
Dosage: 1500 mg am, 1650 mg pm x 14 days
Indication: Colorectal Cancer Metastatic
Start date: 2012-06-22
End date: 2012-08-01
Other drugs received by patient: Roxicodone; Compazine; Ferrous Fumarate; MS Contin; Phenergan HCL; Prinzide; Multi-Vitamin; Compazine
Possible Xeloda side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: male, weighing 51.8 kg (113.9 pounds)
Reactions: Peripheral Coldness, Nausea, Skin Exfoliation, Pain in Extremity, Hypoaesthesia, DRY Skin, Erythema, Dysgeusia, Protein Urine, Fatigue, Diarrhoea, Skin Discolouration, Feeling Hot, Decreased Appetite
Drug(s) suspected as cause:
Avastin
Indication: Colorectal Cancer Metastatic
Start date: 2012-03-01
Xeloda
Dosage: 2000mg in morning, 1500 mg in night
Administration route: Oral
Indication: Colorectal Cancer Metastatic
Start date: 2012-03-01
End date: 2012-07-01
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from Australia on 2012-08-16
Patient: female
Reactions: Fatigue, Pain in Extremity, Palmar-Plantar Erythrodysaesthesia Syndrome, Impaired Gastric Emptying, Gait Disturbance, Skin Fissures
Drug(s) suspected as cause:
Xeloda
Indication: Product Used FOR Unknown Indication
Xeloda
Possible Xeloda side effects in male
Reported by a physician from Korea, Republic of on 2012-08-16
Patient: male, weighing 55.0 kg (121.0 pounds)
Reactions: Pneumonia Fungal, Fatigue, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Xeloda
Dosage: date of most recent dose prior to sae: 31/jan/2012
Administration route: Oral
Indication: Gastric Cancer
Start date: 2011-12-21
Herceptin
Dosage: date of most recent dose prior to sae: 18/jan/2012, 330 mg
Indication: Gastric Cancer
Start date: 2011-12-21
Pertuzumab
Dosage: date of most recent dose prior to sae: 18/jan/2012, 840 mg
Indication: Gastric Cancer
Start date: 2011-12-21
Cisplatin
Dosage: date of most recent dose prior to sae: 18/jan/2012
Indication: Gastric Cancer
Start date: 2011-12-21
Other drugs received by patient: Ramosetron; Artemisia Asiatica; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Tramadol HCL; Albumin; Pethidine HCL; Phytonadione; Tranexamic Acid; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Fresh Frozen Plasma; Tetracosactrin; Aprepitant; Dexamethasone; Loperamide Oxide; Megestrol Acetate; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Dihydrocodeine Bitartrate INJ; Methylprednisolone Sodium Succinate; Ramosetron; Lactobacillus Acidophilus; Joulie's Solution; Potassium Phosphate, Monobasic; Esomeprazole; Esomeprazole; RED Blood Cells; Aprepitant; Chlorpheniramine Maleate; Ranitidine; Ultracet; Potassium Chloride; Esomeprazole; Pethidine HCL; Remifentanil; Famotidine; Potassium Phosphate, Monobasic; Lenograstim; Bisacodyl; Magnesium Sulfate; Sodium Bicarbonate; Potassium Phosphate, Monobasic; Esomeprazole; Tramadol HCL; Albumin; Morphine HCL; Chlorpheniramine Maleate; Pethidine HCL; Dexamethasone; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Fresh Frozen Plasma; Ketoprofen; Fentanyl Citrate
Possible Xeloda side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-15
Patient: female
Reactions: Fatigue, Arteriospasm Coronary, Rash Pruritic
Drug(s) suspected as cause:
Raltitrexed
Indication: Product Used FOR Unknown Indication
Xeloda
Dosage: 2000mg per day
Indication: Breast Cancer Metastatic
Start date: 2012-07-20
End date: 2012-07-23
Tykerb
Dosage: 1000mg at night
Indication: Breast Cancer Metastatic
Start date: 2012-07-20
Other drugs received by patient: Phenergan HCL
Possible Xeloda side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-14
Patient: male, weighing 55.4 kg (121.9 pounds)
Reactions: Back Pain, Vomiting, Nausea, Musculoskeletal Pain, Abasia, Pain, Ill-Defined Disorder, Malaise, Fatigue, Ageusia, Diarrhoea, Gait Disturbance, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Start date: 2012-05-24
End date: 2012-05-31
Xeloda
Administration route: Oral
Indication: Colon Cancer
Start date: 2012-05-07
End date: 2012-05-24
Xeloda
Administration route: Oral
Start date: 2012-06-02
End date: 2012-07-05
Other drugs received by patient: Oxaliplatin
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-13
Patient:
Reactions: Abdominal Pain, Blood Bilirubin Increased, Thrombosis, Anal Examination Abnormal, Hypokalaemia, Fatigue, Proteinuria, Abdominal Distension, Decreased Appetite, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Hyponatraemia, Small Intestinal Obstruction, Hypophosphataemia, Diarrhoea, Alopecia, Dehydration, Neutropenia, Hypertension, Vascular Access Complication
Adverse event resulted in: death
Drug(s) suspected as cause:
Irinotecan Hydrochloride and Irinotecan Hydrochloride
Dosage: given on day 1
Indication: Colorectal Cancer Metastatic
Avastin
Dosage: given on day 1
Indication: Colorectal Cancer Metastatic
Xeloda
Dosage: 1000 mg/m2 twice daily for age below 65 years,750 mg/m2 twice daily for age above 65 years
Administration route: Oral
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from Mexico on 2012-08-13
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Hysterectomy, Fatigue, Malaise, Palmar-Plantar Erythrodysaesthesia Syndrome, Musculoskeletal Stiffness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-21
End date: 2012-07-05
Xeloda
Administration route: Oral
Start date: 2012-08-06
Possible Xeloda side effects in 53 year old male
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient: 53 year old male, weighing 80.4 kg (176.8 pounds)
Reactions: Weight Decreased, Constipation, Rectal Cancer Metastatic, Abdominal Discomfort, Fatigue, Frequent Bowel Movements, Asthenia, Decreased Appetite
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-08
Patient: female, weighing 70.4 kg (154.8 pounds)
Reactions: Pain in Extremity, Eye Irritation, Skin Exfoliation, Dark Circles Under Eyes, Paraesthesia, Oral Discomfort, Fatigue, Surgery, Arthropathy, LIP Blister, Skin Discolouration, Diarrhoea, Joint Swelling, Systemic Lupus Erythematosus, Unevaluable Event
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from Italy on 2012-08-08
Patient:
Reactions: Stomatitis, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Liver Disorder, Mucosal Inflammation, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Indication: Breast Cancer Metastatic
Lapatinib
Indication: Breast Cancer Metastatic
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-08-08
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Fatigue, Dyspnoea, General Physical Health Deterioration, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine Tartrate
Dosage: last dose prior to sae 18 jun 2012
Indication: Breast Cancer
Start date: 2012-04-30
End date: 2012-05-21
Xeloda
Dosage: last dose prior to sae 22 jun 2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-04-30
End date: 2012-06-03
Avastin
Dosage: last dose prior to sae 13/jun/2012
Indication: Breast Cancer
Start date: 2012-04-30
Other drugs received by patient: Furosemide; Amlodipine; Amitriptyline HCL; Novalgin
Possible Xeloda side effects in
Reported by a physician from Spain on 2012-08-07
Patient:
Reactions: Abdominal Pain, Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Death, Fatigue, Diarrhoea, Neutropenia, Hypertension, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Dosage: drug was used for 14 days every 21 days.
Administration route: Oral
Indication: Breast Cancer
Blinded Sorafenib and Blinded Sorafenib
Administration route: Oral
Indication: Breast Cancer
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from Mexico on 2012-08-06
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Fatigue, Pancreatic Carcinoma, Palmar-Plantar Erythrodysaesthesia Syndrome, Depression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Pancreatic Carcinoma
Start date: 2011-10-01
Xeloda
Administration route: Oral
Start date: 2011-11-01
Other drugs received by patient: Gemcitabine Hydrochloride; Cinnarizine; Aspirin; Irbesartan
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-01
Patient: female
Reactions: Nausea, Hypotension, Neoplasm Progression, Hepatic Neoplasm, Fatigue, Lung Disorder, Diarrhoea, Dehydration, Asthenia, Decreased Appetite
Drug(s) suspected as cause:
Tykerb
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-05-18
Xeloda
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Ramipril
Possible Xeloda side effects in 60 year old female
Reported by a physician from Japan on 2012-08-01
Patient: 60 year old female
Reactions: White Blood Cell Count Decreased, Nausea, Neoplasm Progression, Disease Progression, Breast Cancer Metastatic, Fatigue, Diarrhoea, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Dosage: 3 weeks administration followed by 1 week rest
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2006-11-01
End date: 2007-06-01
Xeloda
Dosage: dosage is uncertain.
Administration route: Oral
Other drugs received by patient: Herceptin; Herceptin; Anastrozole; Docetaxel; Anastrozole; Anastrozole; Herceptin; Herceptin
Possible Xeloda side effects in female
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-08-01
Patient: female
Reactions: Fatigue, Hand Fracture
Drug(s) suspected as cause:
Xeloda
Dosage: 500 mg 2
Administration route: Oral
Indication: Colon Cancer
Start date: 2011-02-16
Xeloda
Dosage: 150 mg 3
Administration route: Oral
Start date: 2011-02-16
Possible Xeloda side effects in male
Reported by a physician from United Kingdom on 2012-07-31
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Fatigue, Chest Pain, Circulatory Collapse
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: last dose prior to sae: 08/feb/2012; last dose: 130 mg
Indication: Gastric Cancer
Start date: 2012-02-08
Avastin
Dosage: last dose prior to sae was updated from 08/feb/2012 to 21/feb/2012; last dose taken: 725 mg; date of
Indication: Gastric Cancer
Start date: 2012-02-08
Cisplatin
Dosage: last dose prior to sae: 21/mar/2012; last dose: 127 mg
Start date: 2012-02-09
Xeloda
Dosage: date of most recent dose prior to sae: 04/apr/2012; last dose taken: 1000 in the morning and 1500 in
Administration route: Oral
Start date: 2012-02-09
Epirubicin Hydrochloride
Dosage: last dose: 108 mg; date of most recent dose was updated from 8/feb/2012 to 21/mar/2012
Indication: Gastric Cancer
Start date: 2012-02-08
Xeloda
Dosage: date of most recent dose: 16/feb/2012; dose taken:1500 mg
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-08
Xeloda
Dosage: last dose taken: 725 mg; date of most recent dose: 4/apr/2012
Administration route: Oral
Start date: 2012-02-09
Other drugs received by patient: Ondansetron; Amlodipine; Difflam (United Kingdom); Normacol (United Kingdom); Omeprazole; Docusate Sodium; Acetaminophen and Codeine Phosphate; Omeprazole; Acetaminophen and Codeine Phosphate; Cyclizine; Normacol (United Kingdom); Acetaminophen; Nystatin
Possible Xeloda side effects in 57 year old female
Reported by a consumer/non-health professional from United States on 2012-07-31
Patient: 57 year old female, weighing 104.4 kg (229.7 pounds)
Reactions: Fatigue, Neoplasm Malignant, Paraesthesia
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-27
Patient: 60 year old female
Reactions: Confusional State, Fatigue, Diarrhoea, Oedema Peripheral, Fall, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Tykerb
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Xeloda
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Corticosteroid (Unk Ingredients)
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-25
Patient: female, weighing 67.2 kg (147.8 pounds)
Reactions: Cold-Stimulus Headache, Fatigue
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient: female, weighing 55.4 kg (121.9 pounds)
Reactions: Abdominal Pain Lower, Breast Cancer Metastatic, Fatigue, Body Temperature Increased, Pain
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Ritalin
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-19
Patient: female, weighing 49.0 kg (107.8 pounds)
Reactions: Fatigue, Pain in Extremity, Hepatotoxicity, Rash, Disease Progression
Drug(s) suspected as cause:
Xeloda
Dosage: 1000mg twice per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-05
End date: 2012-04-02
Lapatinib
Indication: Breast Cancer Metastatic
Start date: 2011-12-05
End date: 2012-04-02
Other drugs received by patient: Oxycodone HCL
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-19
Patient: female
Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Herceptin
Indication: Breast Cancer
Xeloda
Indication: Breast Cancer
Possible Xeloda side effects in 60 year old female
Reported by a physician from Japan on 2012-07-19
Patient: 60 year old female
Reactions: White Blood Cell Count Decreased, Fatigue, Diarrhoea, Nausea, Disease Progression, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Dosage: three courses
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2006-11-01
Xeloda
Dosage: dosage is uncertain.
Administration route: Oral
Other drugs received by patient: Anastrozole; Herceptin; Docetaxel; Anastrozole; Anastrozole; Herceptin; Herceptin; Herceptin
Possible Xeloda side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-18
Patient: female
Reactions: Skin Chapped, Weight Decreased, Swelling Face, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Skin Reaction, LIP Pain, Erythema, Malaise, Fatigue, Oral Pain, Influenza
Drug(s) suspected as cause:
Xeloda
Dosage: 2000mg per day
Indication: Breast Cancer
Start date: 2012-01-01
End date: 2012-07-06
Tykerb
Dosage: 1250mg per day
Indication: Breast Cancer Metastatic
Start date: 2012-01-01
End date: 2012-07-06
Other drugs received by patient: Steroid
Page 1 Next >>
|